GANGLIONEUROBLASTOMA
Clinical trials for GANGLIONEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new GANGLIONEUROBLASTOMA trials appear
Sign up with your email to follow new studies for GANGLIONEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo tackles tough childhood cancer
Disease control OngoingThis study tests whether adding two immunotherapy drugs (dinutuximab and sargramostim) to standard chemotherapy is safe and effective for children with high-risk neuroblastoma. About 42 children with newly diagnosed disease will receive this combination during early treatment. Th…
Matched conditions: GANGLIONEUROBLASTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Smart therapy for neuroblastoma: less toxicity, same survival?
Disease control OngoingThis study tests whether adjusting treatment based on each child's tumor biology and how the tumor responds can reduce side effects while still controlling the disease. About 621 children with non-high-risk neuroblastoma are being observed or given tailored therapy instead of sta…
Matched conditions: GANGLIONEUROBLASTOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
New scan may outshine standard test for Kids' rare tumors
Diagnosis OngoingThis study tests whether a special PET/CT scan using a radioactive tracer called 68Ga-DOTATATE can better detect neuroendocrine tumors (like neuroblastoma) in children and young adults up to age 30. The scan is compared to the standard MIBG scan to see which one more clearly show…
Matched conditions: GANGLIONEUROBLASTOMA
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 12, 2026 13:40 UTC
-
Tumor tissue analysis aims to unlock neuroblastoma secrets
Knowledge-focused OngoingThis research study looks at tumor samples from up to 10,000 children newly diagnosed with neuroblastoma or related tumors. Scientists examine the samples for genetic markers and other features to better understand the disease and predict how it may respond to treatment. The goal…
Matched conditions: GANGLIONEUROBLASTOMA
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 17, 2026 05:50 UTC